Press Releases

Press Releases

January 20, 2022
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif. , Jan. 20, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated therapeutics, today announced that on January 18, 2022 , the Company granted four new employees options to purchase a total of 127,000 shares of
Additional Formats
Displaying 11 - 14 of 14